Michael Flax
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
Michael Flax is currently Chairman, Chief Executive & Financial Officer at Nutra Pharma Corp.
since 2024 and a Member of the American Association of Endodontists.
Formerly, Dr. Flax was Director at Nutra Pharma Corp.
from 2002 to 2005.
Education includes an undergraduate degree from Miami University, a graduate degree from St. John's University conferred in 1977, and a doctorate from Georgetown University conferred in 1981.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/05/2026 | 343 ( 0 % ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NUTRA PHARMA CORP. | Director Ejecutivo | 20/03/2024 |
American Association of Endodontists | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| NUTRA PHARMA CORP. | Director Ejecutivo | 01/06/2005 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Nutra Pharma Corp.
Nutra Pharma Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treat pain, autoimmune disorders, viral diseases | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association of Endodontists |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.